Trial Details
AuthorisedBasic Information
| Clinical ID | c5075 |
|---|---|
| Identifier | EUCTR2018-002982-20-GB |
| Trial Title | A Pilot Study to assess the efficacy and safety of reduced dose oral iron in the treatment of iron deficiency anaemia in inflammatory bowel disease patients - Efficacy and safety of low dose oral iron for anaemia in IBD (CAESAR) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Iron deficiency anaemia in inflammatory bowel disease MedDRA version: 20.0.Level: LLT.Classification code 10002062.Term: Anaemia iron deficiency.System Organ Class: 100000004851. MedDRA version: 20.1 |
| Interventions | Trade Name: Ferrous Fumarate SyrupProduct Name: Ferrous Fumarate SyrupProduct Code: Ferrous fumarate syrupPharmaceutical Form: SyrupINN or Proposed INN: Ferrous fumarateCAS Number: 141-01-5Current Sponsor code: NAOther desc |
Participant Information
| Sponsor | Royal Liverpool University Hospital |
|---|---|
| City | NULL |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |